References
- Corradini P., Ladetto M., Pileri A., Tarella C. Clinical relevance of minimal residual disease monitoring in Non-Hodgkin's lymphomas: a critical reappraisal of molecular strategies. Leukemia 1999; 13: 1691–5
- Corradini P., Astolfi M., Cherasco C., Ladetto M., Voena C., Caracciolo D., Pileri A., Tarella C. Molecular monitoring of minimal residual disease in follicular and mantle cell Non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 1997; 89: 724–731
- Andersen N. S., Donovan J. W., Borus J. S., Poor C. M., Neuberg D., Aster J. C., Nadler L. M., Freedman A. S., Gribben J. G. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual desease. Blood 1997; 90: 4212–4221
- Zucca E., Roggero E., Pinotti G., Pedrinis E., Capella C., Venco A., Cavalli F. Patterns of survival in mantle cell lymphoma. Annals of Oncology 1993; 6: 257–262
- Corradini P., Ladetto M., Astolfi M., Voena C., Tarella C., Bacigalupo A., Pileri A. Clinical and molecular remission after allogenic blood transplantation in a patient with mantle-cell lymphoma. British Journal of Haematology 1996; 94: 376–378
- Tarella C., Caracciolo D., Gavarotti P., Bondesan P., Cherasco C., Omedè P., Bregni M., Siena S., Gianni A. M., Pileri A. Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplantation 1995; 16((Suppl. 2))223–228
- Voena C., Ladetto M., Astolfi M., Provan D., Gribben J. G., Boccadoro M., Pileri A., Corradini P. A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia 1997; 11: 1793–1798
- Stewart D. A., Vose J. M., Weisenburger D. D., Anderson J. R., Ruby E. I., Bast M. A., Bierman P. J., Kessinger A., Armitage J. O. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Annals of Oncology 1995; 6((Suppl. 3))263–266
- Seriu T., Yokota S., Nakao M., Misawa S., Takaue Y., Koizumi S., Kawai S., Fujimoto T. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Leukemia 1995; 9((Suppl. 4))615–623
- Campana S., Corradini P., Astolfi M., Ladetto M., Cinque F., Novero D., Tarella C., Pileri A. Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation. Bone Marrow Transplantation 1997; 20: 341–343